Drug Side Effects
Search
CATHETER SITE PHLEBITIS
CATHETER SITE PHLEBITIS
was reported 52 times
These drug classes are most commonly taken by patients reporting CATHETER SITE PHLEBITIS:
#
Drug
Count
0
Nonsteroidal Anti-inflammatory Drug [EPC]
9
1
Corticosteroid [EPC]
8
2
Opioid Agonist [EPC]
6
3
Proton Pump Inhibitor [EPC]
5
4
CD20-directed Cytolytic Antibody [EPC]
4
5
Thalidomide Analog [EPC]
4
6
Atypical Antipsychotic [EPC]
3
7
Benzodiazepine [EPC]
3
8
Dietary Cholesterol Absorption Inhibitor [EPC]
3
9
Thiazide Diuretic [EPC]
3
10
beta-Adrenergic Blocker [EPC]
3
11
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
2
12
Epidermal Growth Factor Receptor Antagonist [EPC]
2
13
Glycopeptide Antibacterial [EPC]
2
14
Insulin Analog [EPC]
2
15
Loop Diuretic [EPC]
2
16
Osmotic Laxative [EPC]
2
17
Platinum-based Drug [EPC]
2
18
Potassium Salt [EPC]
2
19
Sulfonamide Antimicrobial [EPC]
2
20
Tumor Necrosis Factor Blocker [EPC]
2
21
Typical Antipsychotic [EPC]
2
22
Aldosterone Antagonist [EPC]
1
23
Alkylating Drug [EPC]
1
24
Aminoglycoside Antibacterial [EPC]
1
25
Androgen Receptor Inhibitor [EPC]
1
26
Angiotensin Converting Enzyme Inhibitor [EPC]
1
27
Anthelmintic [EPC]
1
28
Antimetabolite [EPC]
1
29
Bispecific CD20-directed CD3 T Cell Engager [EPC]
1
30
CD52-directed Cytolytic Antibody [EPC]
1
31
Claudin 18.2-directed Cytolytic Antibody [EPC]
1
32
Complement Inhibitor [EPC]
1
33
Expectorant [EPC]
1
34
Factor Xa Inhibitor [EPC]
1
35
Folate Analog Metabolic Inhibitor [EPC]
1
36
Human Immunoglobulin G [EPC]
1
37
Integrin Receptor Antagonist [EPC]
1
38
Interferon beta [EPC]
1
39
Kinase Inhibitor [EPC]
1
40
Microtubule Inhibitor [EPC]
1
41
Nucleoside Metabolic Inhibitor [EPC]
1
42
Pediculicide [EPC]
1
43
Penem Antibacterial [EPC]
1
44
Platelet Aggregation Inhibitor [EPC]
1
45
Potassium Channel Blocker [EPC]
1
46
Prostacycline Vasodilator [EPC]
1
47
Proteasome Inhibitor [EPC]
1
48
Pyrimidine Synthesis Inhibitor [EPC]
1
49
SLAMF7-directed Immunostimulatory Antibody [EPC]
1
50
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
1
51
Substance P/Neurokinin-1 Receptor Antagonist [EPC]
1
52
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
53
Xanthine Oxidase Inhibitor [EPC]
1